Heart Failure, Systolic Clinical Trial
Official title:
Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure: A Randomized, Double-blind, Placebo-controlled Study
The study evaluates the effects of metformin treatment on myocardial efficiency in heart
failure patients. 36 patients will be randomized to three months of metformin or placebo
treatment in addition to their regular therapy.
Hypothesis: Treatment with metformin in patients with heart failure has direct or indirect
beneficial effects on left ventricular myocardial oxidative metabolism, myocardial efficiency
and contractile function.
Background: Heart failure (HF) is a common disease and diabetes/insulin resistance are
present in approximately 50 % of HF patients. Metformin is the most commonly prescribed oral
anti-diabetic drug, and registry and experimental studies show beneficial effects of
metformin in HF, but randomized trials are needed.
Objectives: To investigate if treatment with metformin in patients with HF has beneficial
effects on myocardial efficiency,
Design: A randomized, double-blind, placebo-controlled, single-center design. 36 patients
with systolic heart failure will be randomized to either metformin (N = 18) or placebo (N=
18) for 3 months.
Methods: Patients will undergo echocardiography at rest and during exercise along with
[11C]-acetate PET.
Primary outcome parameter is changes in myocardial external efficiency from visit 1 to 3
months of therapy.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03227393 -
The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG
|
N/A | |
| Recruiting |
NCT04528004 -
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
|
Early Phase 1 | |
| Recruiting |
NCT04703842 -
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04522609 -
Electrostimulation of Skeletal Muscles in Patients Listed for a Heart Transplant
|
N/A | |
| Completed |
NCT05475028 -
Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET)
|
||
| Not yet recruiting |
NCT06240403 -
Digoxin and Senolysis in Heart Failure and Diabetes Mellitus
|
Phase 2 | |
| Not yet recruiting |
NCT05988749 -
Digital Remote Home Monitoring for Heart Failure
|
N/A | |
| Recruiting |
NCT04950218 -
The Psoriasis Echo Study
|
||
| Suspended |
NCT04701112 -
Acute Hemodynamic Effects of Pacing the His Bundle in Heart Failure
|
N/A | |
| Completed |
NCT03305692 -
ECG Belt vs. Echocardiographic Optimization of CRT
|
N/A | |
| Recruiting |
NCT05933083 -
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
|
N/A | |
| Enrolling by invitation |
NCT03903107 -
The Fluoroless-CSP Trial Using Electroanatomic Mapping
|
N/A | |
| Withdrawn |
NCT04872959 -
TRANSFORM Heart Failure With Reduced Ejection Fraction
|
N/A | |
| Completed |
NCT02920918 -
Treatment of Diabetes in Patients With Systolic Heart Failure
|
Phase 4 | |
| Completed |
NCT02334891 -
Kyoto Congestive Heart Failure Study
|
||
| Recruiting |
NCT03553303 -
Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin
|
Phase 4 | |
| Recruiting |
NCT04083690 -
Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients
|
N/A | |
| Recruiting |
NCT03830957 -
Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
|
N/A | |
| Recruiting |
NCT06121323 -
Physiological Effects of Lactate in Individuals With Chronic Heart Failure
|
N/A | |
| Completed |
NCT03351283 -
Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure
|
N/A |